NOVABAY PHARMACEUTICALS, INC.
Profile
Company Names
NOVABAY PHARMACEUTICALS, INC.
Addresses
2000 POWELL STREET, SUITE 1150, EMERYVILLE, CA 94608
2000 POWELL STREET, SUITE 1150, EMERYVILLE, CA 94608
2000 POWELL STREET, SUITE 1500, EMERYVILLE, CA 94608
5980 HORTON STREET, SUITE 550, EMERYVILLE, CA 94608
5980 HORTON STREET, SUITE 550, EMERYVILLE, CA 94608
Phone Numbers
(510) 899-8800
Entity Type:
CORPORATION
Industry:
OTHER, PHARMACEUTICALS
Year Incorporated:
> 5 years ago
State Incorporated:
DELAWARE
Total Amount Raised:
$205,299,532.00
Number of Funding Rounds:
15
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
15
2026-01-16
$134,000,000.00
$134,000,000.00
$0.00
14
2024-06-14
$225,953.00
$225,953.00
$0.00
13
2024-03-24
$665,000.00
$665,000.00
$0.00
Debt
12
2023-12-21
$554,808.00
$554,808.00
$0.00
11
2023-05-01
$3,000,000.00
$3,000,000.00
$0.00
Debt
10
2022-09-09
$2,065,500.00
$2,065,500.00
$0.00
Equity
9
2021-11-02
$15,000,000.00
$15,000,000.00
$0.00
Equity
8
2020-07-20
$0.00
$6,829,580.00
$6,829,580.00
7
2020-05-13
$1,030.00
$1,731,030.00
$1,730,000.00
Equity
6
2019-08-13
$4,198,566.00
$4,198,566.00
$0.00
5
2019-06-26
$2,400,000.00
$2,400,000.00
$0.00
Equity
4
2018-02-05
$5,984,000.00
$5,984,000.00
$0.00
Equity
3
2016-05-09
$7,791,000.00
$11,791,000.00
$4,000,000.00
Equity
2
2016-02-16
$2,830,804.00
$2,830,804.00
$0.00
Equity
1
2015-03-06
$26,582,871.00
$26,582,871.00
$0.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
ANDREW
JONES
EXECUTIVE OFFICER
GAIL
MADERIS
DIRECTOR
THOMAS
PAULSON
EXECUTIVE OFFICER
MARK
SIECZKAREK
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2024-03-24
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2023-05-01
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2022-09-09
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2021-11-02
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2020-05-13
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2019-08-13
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2019-06-26
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2018-02-05
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2016-05-09
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2016-02-16
D/A
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2015-03-06
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2015-03-06
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
CHINA KINGTON ASSET MANAGEMENT CO. LTD
NONE
NONE
NONE
CHINA KINGTON ASSET MANAGEMENT CO. LTD.
NONE
NONE
NONE
CHINA KINGTON ASSET MANAGEMENT CO. LTD.
NONE
NONE
NONE
CHINA KINGTON ASSET MANAGEMENT CO. LTD.
NONE
NONE
NONE
CHINA KINGTON ASSET MANAGEMENT CO. LTD.
NONE
N/A
NONE
MAXIM GROUP LLC
NONE

